Neoleukin Therapeutics Provides Update on COVID-19 Impact on Corporate and Clinical Development Activities [Canadian Business Journal (Canada)]
Neoleukin Therapeutics, Inc. (NLTX)
Company Research
Source: Canadian Business Journal
SEATTLE, April 09, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. “Neoleukin” (NASDAQ:NLTXde novo“During this unprecedented time, protecting the health and well-being of our employees and community is a top priority. In addition, we are focused on maintaining continuity of our research, development and business activities while balancing potential impacts from the COVID-19 pandemic,” said Jonathan Drachman, M.D., Chief Executive Officer of Neoleukin. “We are continuing our efforts toward submission of an Investigational New Drug application for our lead therapeutic candidate, NL-201; and we look forward to presenting additional preclinical data and research highlighting the potential applications of ourOur People and OperationsAs of March 9, 2020, Neoleukin transitioned to a work from home policy for its employees and discontinued all work-related travel. Business-critical research and development work has continued, adhering to guidelines to ensure employee safety. The company
Show less
Read more
Impact Snapshot
Event Time:
NLTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NLTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NLTX alerts
High impacting Neoleukin Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics